Answer
Vemurafenib is indicated as monotherapy for adults with BRAF V600 mutation-positive unresectable or metastatic melanoma.
Sources for this answer
- Zelboraf 240 mg Film-coated TabletsRoche Products Limited · emc · SmPC §4.1 Therapeutic Indications · Version 30Document updated
Sources checked